col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


80 Results       Page 1

 [1] 
Future Medicine: Future Microbiology
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Jan―31 Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza
2 [GO] 2024―Jan―31 Triple in silico targeting of IMPDH enzyme and RNA-dependent RNA polymerase of both SARS-CoV-2 and Rhizopus oryzae Abdel-moniem S Hassan, Abdo A Elfiky, Alaa M Elgohary
3 [GO] 2023―Nov―01 Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients Murat Karamese, Abdullah Gumus, Eray Atalay, Emin E Tutuncu
4 [GO] 2023―Oct―20 Plain language summary: Did the COVID-19 pandemic change the resistance to current antifungal medicines? Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Paul R Rhomberg, Mariana Castanheira
5 [GO] 2023―Oct―18 Characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in southeast Mexico Jorge A Rangel-Méndez, Luciola Jaimes-Gurrusquieta, Juan F Sánchez-Cruz, Ma I Zarate-Murillo, Jessica Domínguez-Méndez, Hugo A Laviada-Molina, Daniel Casares-González, Elideth M Flores-Flores
6 [GO] 2023―Sep―26 Has coronavirus disease 2019 changed clinical microbiology laboratories forever? Joseph M Blondeau, Jennifer Coetzee
7 [GO] 2023―Sep―05 Pandemic predictions and precautionary preparations: lessons from history Thomas H Pennington
8 [GO] 2023―Jul―14 Antibiotic dispensing during first year of COVID-19 pandemic in Brazilian public hospitals Maria LS Pereira, Davi AC Mothé, Kézia S Pinheiro, Sarah S Gonçalves, Kênia V Santos
9 [GO] 2023―Mar―14 Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study Gulsah Tuncer, Ceyda Geyiktepe-Guclu, Serkan Surme, Evren Canel-Karakus, Hatice Erdogan, Osman F Bayramlar, Cansu Belge, Ridvan Karahasanoglu, Betul Copur, Meltem Yazla, Esra Zerdali, Inci Y Nakir, Nihal Yildirim, Bedriye Kar, Mediha Bozkurt, Kubra Karanalbant, Burcu Atasoy, Hindirin Takak, Serap Simsek-Yavuz, Rustu Turkay, Mehmet M Sonmez, Gonul Sengoz, Filiz Pehlivanoglu
10 [GO] 2023―Jan―17 Mucormycosis in the COVID-19 scenario beyond hospitalized patients Alexandro Bonifaz, Andrés Tirado-Sánchez, Javier Araiza, María Luisa Hernández-Medel
11 [GO] 2022―Oct―06 Acinetobacter baumannii infections resistant to treatment: warning signs from the COVID-19 pandemic Ryan C Ellis, Elena K Roberts, Jennifer T Grier, Steven E Fiester
12 [GO] 2022―Sep―28 Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Filiz Pehlivanoglu, Gonul Sengoz
13 [GO] 2022―Sep―16 Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21 Lucyana LC Coutinho, Caroline N Oliveira, Polianna LMM Albuquerque, Sandra MB Mota, Gdayllon C Meneses, Alice MC Martins, Geraldo BS Junior, Marco AF Clementino, Rafhaella NDG Gondim, Alexandre Havt, Luciano PG Cavalcanti, Juliana NU Yaochite
14 [GO] 2022―Sep―16 Comment on: ‘Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients’ Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-García, Javier Mancilla-Galindo
15 [GO] 2022―Aug―04 Follow-up study of anti-SARS-CoV-2 IgG antibody response in COVID-19 patients up to 6 months after infection Atalay Eray, Karamese Murat, Gumus Abdullah, Kahraman Ihsan, Kelesoglu Royca, Ozgur Didem, Tutuncu E Ediz
16 [GO] 2022―Jul―28 Role of the PD-1 and PD-L1 axis in COVID-19 Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry
17 [GO] 2022―Jul―28 First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria Denis Niyazi, Borislava Toncheva, Tsvetan Tonchev, Deyan Dzhenkov, Kalin Kalchev, Temenuga Stoeva
18 [GO] 2022―Jul―28 Coinfection with Strongyloides and Ascaris in a COVID-19-positive male presenting with acute abdomen: a case report Sweta Singh, Uday S Singh
19 [GO] 2022―Jul―28 SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure Georgi Merhi, Jad Koweyes, Tamara Salloum, Charbel Al Khoury, Siwar Haidar, Sima Tokajian
20 [GO] 2022―Jul―26 G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19 Abir Mondal, Soumyadeep Mukherjee, Waseem Dar, Prince Upadhyay, Anand Ranganathan, Soumya Pati, Shailja Singh
21 [GO] 2022―Jul―26 Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha Tjaša Ž Čretnik, Matjaž Retelj, Sandra Janežič, Aleksander Mahnič, Tine Tesovnik, Robert Šket, Barbara J Bizjan, Samo Jeverica, Mateja Ravnik, Mitja Rak, Mateja Borinc, Maja Rupnik, Tadej Battelino, Marko Pokorn, Jernej Kovač
22 [GO] 2022―May―05 Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19? Sheila Santa, Derek A Doku, Charles O Olwal, Charles A Brown, Emmanuel A Tagoe, Osbourne Quaye
23 [GO] 2022―May―05 Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective Abdo A Elfiky
24 [GO] 2022―Apr―25 Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19 Malihe Naderi, Seyed Amir Soltani, Akram Taheri Rad, Zahra Mehrbakhsh, Sina Sodagar, Alireza Tahamtan, Seyedeh Sedigheh Hosseini
25 [GO] 2022―Apr―20 Clostridioides difficile co-infection in patients with COVID-19 Roman Maslennikov, Vladimir Ivashkin, Anna Ufimtseva, Elena Poluektova, Anatoly Ulyanin
26 [GO] 2022―Apr―01 Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children Danilo Buonsenso, Ferran Espuny Pujol, Daniel Munblit, Davide Pata, Sammie McFarland, Frances K Simpson
27 [GO] 2022―Mar―30 Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2 Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, Sundararaj S Jeremiah, Michiharu Kudo, Akihide Ryo
28 [GO] 2022―Mar―14 Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis Kevin Bouiller, Nathan Peiffer-Smadja, Muge Cevik, Katharina Last, Ivana A Antunović, Anja Šterbenc, Maria J Lopes, Aleksandra Barac, Valentijn Schweitzer, Sarah Dellière
29 [GO] 2022―Mar―14 Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest Abdullah Al Saba, Maisha Adiba, Sajib Chakraborty, AHM Nurun Nabi
30 [GO] 2022―Feb―24 Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki
31 [GO] 2022―Feb―15 Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic Daniele Focosi, Fabrizio Maggi, Scott McConnell, Arturo Casadevall
32 [GO] 2022―Feb―09 Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody
33 [GO] 2022―Jan―19 Scrub typhus in two COVID-19 patients: a diagnostic dilemma Chandan Kumar Thakur, Priyam Batra, EV Vinayaraj, K Sreenath, Nisha Rathor, Urvashi B Singh, Ridhima Bhatia, Ajisha Aravindan, Naveet Wig, Randeep Guleria, Rama Chaudhry
34 [GO] 2022―Jan―19 Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank Michael Frank
35 [GO] 2021―Dec―17 Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 Iftikhar Nadeem, Louise Jordon, Masood Ur Rasool, Noor Mahdi, Ritesh Kumar, Zahra Rehman, Craig J Tilley, Simran Kang, Amrita Rai, She Lok, Alison McMillan
36 [GO] 2021―Dec―17 Inflammation at the crossroads of Helicobacter pylori and COVID-19 Ileana Gonzalez, Cristian Lindner, Ivan Schneider, Miguel A Morales, Armando Rojas
37 [GO] 2021―Nov―23 Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients Serkan Surme, Gulsah Tuncer, Betul Copur, Esra Zerdali, Inci Yilmaz Nakir, Meltem Yazla, Osman Faruk Bayramlar, Ahmet Buyukyazgan, Ayse Ruhkar Kurt Cinar, Hatice Balli, Yesim Kurekci, Filiz Pehlivanoglu, Gonul Sengoz
38 [GO] 2021―Nov―23 Drug-based therapeutic strategies for COVID-19-infected patients and their challenges Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, Rahil Fazlinejad, Soliman Mohammadi-Samani, Negar Firouzabadi, Majid Hosseini, Fatemeh Farjadian
39 [GO] 2021―Nov―11 Current status of therapeutic approaches and vaccines for SARS-CoV-2 Braira Wahid, Anam Amir, Ayesha Ameen, Muhammad Idrees
40 [GO] 2021―Nov―10 Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV Sarah Aherfi, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, Didier Raoult
41 [GO] 2021―Oct―25 Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection Muhammad Asif, Mohammad Saleem, Hafiza Sidra Yaseen, Ashwaq HS Yehya, Malik Saadullah, Hafiz Muhammad Zubair, Chern E Oon, Pegah Moradi Khaniabadi, Syed Haroon Khalid, Ikram Ullah Khan
42 [GO] 2021―Oct―22 A comparative study of the mental health impact of the COVID-19 pandemic on health care professionals in India Jitender Jakhar, Partha Sarathi Biswas, Mahima Kapoor, Amandeep Panghal, Amit Meena, Harsha Fani, Pradip Kharya
43 [GO] 2021―Oct―07 Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey Murat Karamese, Didem Ozgur, Emin E Tutuncu
44 [GO] 2021―Sep―01 Coronaviruses construct an interconnection way with ERAD and autophagy Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour
45 [GO] 2021―Sep―01 SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi
46 [GO] 2021―Jul―28 Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok
47 [GO] 2021―Jul―28 Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi
48 [GO] 2021―Jul―05 Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, Saliha Kazci, Mursel Karadavut, Abdullah Gumus, Gozde Apaydin, Necati Mumcu, Onur Coruh, Emin E Tutuncu
49 [GO] 2021―Jun―24 Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni
50 [GO] 2021―Jun―04 Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau Joseph Blondeau
51 [GO] 2021―May―17 Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez Peter Hotez
52 [GO] 2021―May―11 Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response Xin Chen, Mingli Gu, Tengda Li, Yi Sun
53 [GO] 2021―May―07 Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris
54 [GO] 2021―Apr―13 Herd immunity: could it bring the COVID-19 pandemic to an end? Thomas Hugh Pennington
55 [GO] 2021―Apr―13 The interplay of SARS-CoV-2 and Clostridioides difficile infection Sahil Khanna, Colleen S Kraft
56 [GO] 2021―Mar―12 COVID-19 pneumonia: do not leave the corticosteroids behind! Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa
57 [GO] 2021―Feb―11 Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
58 [GO] 2021―Jan―25 COVID-19: it is all about sepsis Jean-Louis Vincent
59 [GO] 2021―Jan―19 Review of the use of nasal and oral antiseptics during a global pandemic Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar
60 [GO] 2021―Jan―18 The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 Mayra Cuéllar-Cruz
61 [GO] 2021―Jan―06 Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, Abolghasem Jouyban, Susan CJ Sumner
62 [GO] 2021―Jan―06 Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye
63 [GO] 2020―Dec―22 COVID-19: mask efficacy is dependent on both fabric and fit Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, Liam Lewis, Niall Smith, Roy D Sleator
64 [GO] 2020―Nov―24 Chloroquine/hydroxycloroquine and COVID-19: need to know more about Antonio Cassone, Licia Iacoviello, Roberto Cauda
65 [GO] 2020―Nov―20 The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic Lígia N de M Ribeiro, Belchiolina B Fonseca
66 [GO] 2020―Nov―12 Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, Meenakshi Ahluwalia, Yasmeen Jilani, Alka Chaubey, Madhuri Hegde, Vamsi Kota, Amyn Rojiani, Ravindra Kolhe
67 [GO] 2020―Nov―06 Clinical microbiology laboratories and COVID-19: the calm before the storm Joseph M Blondeau
68 [GO] 2020―Nov―06 Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation Michael B Yakass, Osbourne Quaye, Bryan J Woodward
69 [GO] 2020―Nov―03 Coronavirus pandemic: treatment and future prevention Kenneth Lundstrom
70 [GO] 2020―Oct―21 Systemic mycoses: a potential alert for complications in COVID-19 patients Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases
71 [GO] 2020―Oct―21 Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
72 [GO] 2020―Sep―21 Potential alteration of COVID-19 by beta-mercaptoethanol Robert E Click
73 [GO] 2020―Sep―03 SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris
74 [GO] 2020―Aug―27 Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh
75 [GO] 2020―Aug―26 Phages in the fight against COVID-19? Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski
76 [GO] 2020―Aug―14 Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, Peng Liu, Quan-Xu Ge, Ming-Yi Wang
77 [GO] 2020―Jul―17 COVID-19: in the absence of vaccination - ‘mask-the-nation’ Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith
78 [GO] 2020―Jul―14 N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester
79 [GO] 2020―Jul―08 The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani
80 [GO] 2020―Jun―11 Focus on a 2019-novel coronavirus (SARS-CoV-2) Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang
 [1] 

80 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.011 sec